13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q2 2023. See the latest, Q2 2026 →
Reported value
$15.10B
+3.8% on the quarter before
Positions
222
8 new · 7 sold out
Top 10
49.0%
of the value
Est. gain
+$1.14B
on stocks held all quarter
Est. return
+8.5%
on those stocks since Q1 2023
Positions as of Jun 30, 2023, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2023. Striped tiles are options.
Largest buys
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Palantir~$104.9MNew · 0.0% → 0.7%+6,842,989 shares
- Teradyne~$62.8MAdded · 0.4% → 0.9%+563,791 shares
- Meta~$57.3MNew · 0.0% → 0.4%+199,745 shares
- UiPath~$56.2MAdded · 5.4% → 5.3%+3,388,821 shares
- Twilio~$50.1MAdded · 2.9% → 3.0%+788,183 shares
- Coinbase~$24.7MAdded · 5.5% → 5.7%+345,866 shares
- Block~$17.0MAdded · 4.9% → 4.7%+256,004 shares
- TSMC~$14.6MNew · 0.0% → 0.1%+144,738 shares
- Verve Therapeutics Inc~$12.5MAdded · 0.4% → 0.6%+668,760 shares
- Pagerduty Inc~$12.4MAdded · 2.4% → 1.5%+549,680 shares
Largest sells
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Exact Sciences Corp~$396.6MCut · 5.3% → 4.4%−4,224,089 shares
- Shopify Inc~$330.2MCut · 4.6% → 3.8%−5,110,995 shares
- Tesla~$156.0MCut · 7.8% → 8.4%−596,014 shares
- Draftkings Inc~$156.0MCut · 3.2% → 3.2%−5,870,792 shares
- 10x Genomics Inc~$58.2MCut · 1.6% → 1.2%−1,041,774 shares
- Nvidia~$50.2MCut · 0.8% → 0.8%−118,587 shares
- Crispr Therapeutics Ag~$36.6MCut · 2.5% → 2.7%−651,741 shares
- Roku Inc~$33.6MCut · 5.6% → 5.1%−525,139 shares
- Zoom~$27.5MCut · 5.5% → 4.7%−404,727 shares
- Schrödinger~$19.4MCut · 0.7% → 1.2%−389,354 shares
Holdings
As of Jun 30, 2023. Changes are in shares against Mar 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −11% · price +26.2% | 8.4% | $1.27B | +$263.1M | ||||||||
| CoinbaseCommon Stock · shares +2.9% · price +5.9% | 5.7% | $867.3M | +$46.9M | ||||||||
| UiPathCommon Stock · shares +7.5% · price −5.6% | 5.3% | $800.0M | −$44.4M | ||||||||
| Roku IncCommon Stock · shares −4.2% · price −2.8% | 5.1% | $764.9M | −$22.2M | ||||||||
| BlockCommon Stock · shares +2.4% · price −3.0% | 4.7% | $714.1M | −$21.8M | ||||||||
| ZoomCommon Stock · shares −3.7% · price −8.1% | 4.7% | $710.2M | −$62.4M | ||||||||
| Exact Sciences CorpCommon Stock · shares −37% · price +38.5% | 4.4% | $671.9M | +$186.7M | ||||||||
| Shopify IncCommon Stock · shares −37% · price +34.8% | 3.8% | $573.3M | +$147.9M | ||||||||
| Unity Software IncCommon Stock · shares −3.0% · price +33.8% | 3.4% | $518.2M | +$131.1M | ||||||||
| Teladoc Health IncCommon Stock · shares −1.2% · price −2.2% | 3.4% | $515.1M | −$11.8M | ||||||||
| Draftkings IncCommon Stock · shares −25% · price +37.2% | 3.2% | $479.9M | +$130.2M | ||||||||
| TwilioCommon Stock · shares +13% · price −4.5% | 3.0% | $447.8M | −$18.8M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares −8.2% · price +24.1% | 2.7% | $412.0M | +$80.1M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares −3.2% · price +9.4% | 2.6% | $388.5M | +$33.4M | ||||||||
| RobloxCommon Stock · shares +3.2% · price −10.4% | 2.5% | $375.5M | −$42.2M | ||||||||
| Pacific Biosciences Of CaliforCommon Stock · shares −4.0% · price +14.9% | 2.3% | $354.2M | +$45.8M | ||||||||
| RobinhoodCommon Stock · shares +0.6% · price +2.8% | 2.1% | $318.6M | +$8.6M | ||||||||
| Ginkgo Bioworks Holdings IncCommon Stock · shares +3.0% · price +39.8% | 2.1% | $315.7M | +$87.3M | ||||||||
| Beam Therapeutics IncCommon Stock · shares −2.2% · price +4.3% | 1.8% | $267.7M | +$11.0M | ||||||||
| Pagerduty IncCommon Stock · shares +5.6% · price −35.7% | 1.5% | $233.3M | −$122.9M | ||||||||
| Veracyte IncCommon Stock · shares −6.9% · price +14.2% | 1.3% | $199.4M | +$24.8M | ||||||||
| SchrödingerCommon Stock · shares −10.0% · price +89.6% | 1.2% | $175.6M | +$83.0M | ||||||||
| 10x Genomics IncCommon Stock · shares −25% · price +0.1% | 1.2% | $173.9M | +$155,661 | ||||||||
| Twist Bioscience CorpCommon Stock · shares −3.1% · price +35.7% | 0.94% | $142.4M | +$37.4M | ||||||||
| TeradyneCommon Stock · shares +93% · price +3.6% | 0.86% | $130.5M | +$2.3M | ||||||||
| Total · 222 positions | 100% | $15.10B | +$1.14B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2023 to Q2 2023: 213 stocks held throughout, up $1.14B (+8.5%).
- Tesla+$263.1M+26%
- Exact Sciences Corp+$186.7M+38%
- Shopify Inc+$147.9M+35%
- Unity Software Inc+$131.1M+34%
- Draftkings Inc+$130.2M+37%
- 2u Inc−$24.8M−41%
- Roblox−$42.2M−10%
- UiPath−$44.4M−6%
- Zoom−$62.4M−8%
- Pagerduty Inc−$122.9M−36%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |